Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Cagrilintide as a standalone drug does not appear to be pursuing separate FDA approval at this time, as Novo Nordisk is focusing on the combination product
However, that is not the end of the story
Heres the step-by-step process: Make sure youre in a clean environment to minimize the risk of infection
Claims (4) Applications Claiming Priority (3) Related Parent Applications (2) Publications (2) Family ID=6331195 Family Applications (2) Family Applications Before (1) Country Status (8) Cited By (1) Families Citing this family (38) Citations (1) Family Cites Families (5) 1987 1987-07-09 DE DE19873722647 patent/DE3722647A1/en not_active Ceased 1988 1988-07-08 AU AU19944/88A patent/AU1994488A/en not_active Abandoned 1988-07-08 JP JP63505693A patent/JP2851289B2/en not_active Expired - Lifetime 1988-07-08 EP EP88905695A patent/EP0327612B1/en not_active Expired - Lifetime 1988-07-08 AT AT94108938T patent/ATE188968T1/en not_active IP Right Cessation 1988-07-08 EP EP94108938A patent/EP0655460B1/en not_active Expired - Lifetime 1988-07-08 AT AT88905695T patent/ATE121942T1/en not_active IP Right Cessation 1988-07-08 WO PCT/DE1988/000427 patent/WO1989000427A1/en not_active Ceased 1996 1996-07-22 LV LV960291A patent/LV5793B4/en unknown 1997 1997-06-05 HK HK74697A patent/HK74697A/en not_active IP Right Cessation 1998 1998-07-22 JP JP10206738A patent/JPH11106349A/en active Pending 1998-07-22 JP JP10206743A patent/JPH11147836A/en active Pending
